Summit Therapeutics (SMMT) Amortizatization of Intangibles (2019 - 2026)

Summit Therapeutics (SMMT) has 4 years of Amortizatization of Intangibles data on file, last reported at $3.0 million in Q2 2026.

• Quarterly Amortizatization of Intangibles rose 190.22% year-over-year to $3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.2 million (up 123.85% YoY) and the FY2025 annual result came in at $7.0 million, up 171.97% from the prior year.
• Amortizatization of Intangibles slipped to $3.0 million in Q2 2026, from $4.2 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.2 million in Q1 2026 to a low of -$2.4 million in Q4 2024.
• A 4-year average of $1.6 million and a median of $2.3 million in 2023 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2024 — Amortizatization of Intangibles tumbled 1229.81% — and 2025, when it surged 637.81%.
• Tracing SMMT's Amortizatization of Intangibles over 4 years: stood at $208000.0 in 2023, then plunged by 1229.81% to -$2.4 million in 2024, then jumped by 228.38% to $3.0 million in 2025, then slipped by 1.59% to $3.0 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $3.0 million (Q2 2026), $4.2 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.